CL

CEL AI PLCLSE CEL AI Stock Report

Last reporting period 29 Feb, 2024

Updated 25 Oct, 2024

Last price

Market cap $B

0.001

Micro

Exchange

XLON - London Stock Exchange

CLAI.L Stock Analysis

CL

Uncovered

CEL AI PLC is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

19/100

Low score

Market cap $B

0.001

Dividend yield

Shares outstanding

602.25 B

Cel AI Plc engages in the provision of consumer products based on biosynthetic cannabinoids. The firm is engaged in developing and marketing premium skincare and wellness products that help people look, feel and function better. The Company’s primary focus is on three product verticals: Feel Better, Look Better and Function Better. These three verticals encompass Cellular Goods' premium cannabigerol (CBG) skincare and CBD wellness. The firm's products include rejuvenating cannabinoid face serum, SPF 25 rejuvenating day cream, rejuvenating night cream, rejuvenating day mousse, nourishing face oil travel size and various others. The Company’s products are available direct to the consumer through its Website, e-commerce sites, such as Amazon and through physical retail partnerships.

View Section: Eyestock Rating